What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

IntroductionMinimum clinically important difference (MCID) is a measure that defines the minimum amount of change in an objective score of a clinical test that must be reached for that change to be clinically noticeable. We aimed to find the MCID for patients with predominantly negative symptoms of...

Full description

Bibliographic Details
Main Authors: Pál Czobor, Barbara Sebe, Károly Acsai, Ágota Barabássy, István Laszlovszky, György Németh, Toshi A. Furukawa, Stefan Leucht
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Psychiatry
Subjects:
minimum clinically important difference
negative symptoms
schizophrenia
MCID
clinical trial
cariprazine
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.816339/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.816339/full

Similar Items